Kexing Biopharm Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 688136?
Owner Type	Number of Shares	Ownership Percentage
Private Companies	2,323,274	1.18%
Institutions	19,899,791	10.1%
General Public	41,245,132	20.9%
Individual Insiders	133,849,881	67.8%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 78.68% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
67.7%	Xueqin Deng	133,542,472	CN¥2.6b	7,470%	no data
2.85%	CITIC Securities Company Limited, Asset Management Arm	5,619,572	CN¥110.8m	99%	0.12%
0.98%	Shanghai Changfu Investment Management Co., Ltd.	1,930,612	CN¥38.1m	0%	7.12%
0.81%	Rongtong Fund Management Co. Ltd.	1,600,000	CN¥31.6m	6.67%	0.11%
0.67%	Qingdao Hengyi Enterprise Management Partnership Enterprise (Limited Partnership)	1,322,543	CN¥26.1m	0%	no data
0.56%	HSBC Global Asset Management (UK) Limited	1,111,541	CN¥21.9m	0%	no data
0.51%	Qingdao Yuzao Enterprise Management Partnership Enterprise (Limited Partnership)	1,000,731	CN¥19.7m	0%	no data
0.49%	ICBC Credit Suisse Asset Management Co., Ltd.	967,791	CN¥19.1m	43.1%	0.01%
0.46%	UBS Asset Management AG	904,390	CN¥17.8m	0%	no data
0.45%	Morgan Stanley, Investment Banking and Brokerage Investments	884,742	CN¥17.4m	0%	no data
0.4%	Huatai Securities (Shanghai) Asset Management Co., Ltd.	784,403	CN¥15.5m	0%	0.12%
0.35%	Gfund Management Co., Ltd.	700,038	CN¥13.8m	0%	0.05%
0.34%	National Council for Social Security Fund	666,405	CN¥13.1m	-11.5%	no data
0.29%	China Merchants Fund Management Company Ltd.	575,380	CN¥11.3m	0%	0.01%
0.28%	Dacheng Fund Management Co., Ltd.	556,206	CN¥11.0m	-8.05%	0.01%
0.27%	Hwabao WP Fund Management Co., Ltd	524,850	CN¥10.3m	0%	0.01%
0.26%	First State Cinda Fund Management Company Limited	515,408	CN¥10.2m	0%	0.02%
0.26%	GF Fund Management Co., Ltd.	507,095	CN¥10.0m	0%	no data
0.25%	AXA SPDB Investment Managers Co., Ltd.	483,625	CN¥9.5m	0%	0.1%
0.23%	Hotland Innovation Asset Management Co., Ltd.	458,669	CN¥9.0m	0%	0.56%
0.084%	Bank of China Investment Management Co., Ltd.	165,109	CN¥3.3m	0%	0.01%
0.06%	Chang Xin Asset Management Corporation Ltd.	118,500	CN¥2.3m	0%	0.01%
0.059%	Zhong Ou Fund Management Co., Ltd	117,045	CN¥2.3m	0%	no data
0.053%	E Fund Management Co., Ltd.	104,379	CN¥2.1m	0%	no data
0.05%	Penghua Fund Management Co., Ltd.	98,200	CN¥1.9m	0%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/24 06:08
End of Day Share Price	2024/12/24 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Kexing Biopharm Co., Ltd. is covered by 3 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Kai Wang	Citic Securities Co., Ltd.
Yin Ye	Ping An Securities Co. Ltd.
Song Yang	Tianfeng Securities Brokerage Co., Ltd